86 related articles for article (PubMed ID: 25393625)
1. Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues.
Ferrero S; Vaira V; Del Gobbo A; Vicentini L; Bosari S; Beck-Peccoz P; Mantovani G; Spada A; Lania AG
Histol Histopathol; 2015 Apr; 30(4):473-8. PubMed ID: 25393625
[TBL] [Abstract][Full Text] [Related]
2. Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues: A systematic review.
Del Gobbo A; Peverelli E; Treppiedi D; Lania A; Mantovani G; Ferrero S
Exp Cell Res; 2016 Aug; 346(1):85-90. PubMed ID: 27321957
[TBL] [Abstract][Full Text] [Related]
3. Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation.
Mantovani G; Lania AG; Bondioni S; Peverelli E; Pedroni C; Ferrero S; Pellegrini C; Vicentini L; Arnaldi G; Bosari S; Beck-Peccoz P; Spada A
Exp Cell Res; 2008 Jan; 314(1):123-30. PubMed ID: 17904549
[TBL] [Abstract][Full Text] [Related]
4. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.
Sandrini F; Matyakhina L; Sarlis NJ; Kirschner LS; Farmakidis C; Gimm O; Stratakis CA
Genes Chromosomes Cancer; 2002 Oct; 35(2):182-92. PubMed ID: 12203783
[TBL] [Abstract][Full Text] [Related]
5. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein.
Lania AG; Mantovani G; Ferrero S; Pellegrini C; Bondioni S; Peverelli E; Braidotti P; Locatelli M; Zavanone ML; Ferrante E; Bosari S; Beck-Peccoz P; Spada A
Cancer Res; 2004 Dec; 64(24):9193-8. PubMed ID: 15604292
[TBL] [Abstract][Full Text] [Related]
6. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of PRKAR1A and PRKAR2B depletion on signaling pathways, cell growth, and cell cycle control of adrenocortical cells.
Basso F; Rocchetti F; Rodriguez S; Nesterova M; Cormier F; Stratakis CA; Ragazzon B; Bertherat J; Rizk-Rabin M
Horm Metab Res; 2014 Nov; 46(12):883-8. PubMed ID: 25268545
[TBL] [Abstract][Full Text] [Related]
8. Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.
Vincent-Dejean C; Cazabat L; Groussin L; Perlemoine K; Fumey G; Tissier F; Bertagna X; Bertherat J
Eur J Endocrinol; 2008 Jun; 158(6):829-39. PubMed ID: 18505904
[TBL] [Abstract][Full Text] [Related]
9. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.
Robinson-White A; Meoli E; Stergiopoulos S; Horvath A; Boikos S; Bossis I; Stratakis CA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2380-8. PubMed ID: 16569736
[TBL] [Abstract][Full Text] [Related]
10. Haploinsufficiency for either one of the type-II regulatory subunits of protein kinase A improves the bone phenotype of Prkar1a+/- mice.
Liu S; Saloustros E; Mertz EL; Tsang K; Starost MF; Salpea P; Faucz FR; Szarek E; Nesterova M; Leikin S; Stratakis CA
Hum Mol Genet; 2015 Nov; 24(21):6080-92. PubMed ID: 26246497
[TBL] [Abstract][Full Text] [Related]
11. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
[TBL] [Abstract][Full Text] [Related]
12. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
[TBL] [Abstract][Full Text] [Related]
14. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma.
Loilome W; Juntana S; Namwat N; Bhudhisawasdi V; Puapairoj A; Sripa B; Miwa M; Saya H; Riggins GJ; Yongvanit P
Int J Cancer; 2011 Jul; 129(1):34-44. PubMed ID: 20824711
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase A subunit expression is altered in Bloom syndrome fibroblasts and the BLM protein is increased in adrenocortical hyperplasias: inverse findings for BLM and PRKAR1A.
Heyerdahl SL; Boikos S; Horvath A; Giatzakis C; Bossis I; Stratakis CA
Horm Metab Res; 2008 Jun; 40(6):391-7. PubMed ID: 18401830
[TBL] [Abstract][Full Text] [Related]
16. A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues.
Kirschner LS; Kusewitt DF; Matyakhina L; Towns WH; Carney JA; Westphal H; Stratakis CA
Cancer Res; 2005 Jun; 65(11):4506-14. PubMed ID: 15930266
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase A alterations in endocrine tumors.
Yu B; Ragazzon B; Rizk-Rabin M; Bertherat J
Horm Metab Res; 2012 Sep; 44(10):741-8. PubMed ID: 22752956
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors.
Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos S; Robinson-White A; Lenherr S; Weinberg FD; Claflin E; Meoli E; Cho-Chung YS; Stratakis CA
Cancer Res; 2004 Dec; 64(24):8811-5. PubMed ID: 15604237
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning, chromosomal localization of human peripheral-type benzodiazepine receptor and PKA regulatory subunit type 1A (PRKAR1A)-associated protein PAP7, and studies in PRKAR1A mutant cells and tissues.
Liu J; Matyakhina L; Han Z; Sandrini F; Bei T; Stratakis CA; Papadopoulos V
FASEB J; 2003 Jun; 17(9):1189-91. PubMed ID: 12692076
[TBL] [Abstract][Full Text] [Related]
20. Expression of the ring ligase PRAJA2 in thyroid cancer.
Cantara S; D'Angeli F; Toti P; Lignitto L; Castagna MG; Capuano S; Prabhakar BS; Feliciello A; Pacini F
J Clin Endocrinol Metab; 2012 Nov; 97(11):4253-9. PubMed ID: 22948757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
